NCT01852604: Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005) |
|
|
| Completed | 2 | 143 | US | Samatasvir, Simeprevir, Ribavirin (RBV), TMC647055, Ritonavir (RTV), Pegylated interferon (Peg-IFN), Samatasvir matching placebo | Merck Sharp & Dohme LLC, Janssen Research & Development, LLC | Chronic Hepatitis C Virus | 04/15 | 04/15 | | |